Skip navigation
Skip navigation

Reappraising prazosin for night-time symptoms in post-traumatic stress disorder [LETTERS]

Maguire, Paul; Looi, Jeffrey


Post-traumatic stress disorder (PTSD) has a lifetime prevalence of approximately 10% and is associated with significant levels of psychological distress, impaired functioning and comorbidity (Kessler et al., 2005). Sleep disturbances are particularly common in PTSD and may have marked negative clinical consequences. Prazosin, a centrally acting sympatholytic alpha1-adrenergic receptor antagonist, may normalize heightened adrenergic neurotransmission in patients with PTSD. Khachatryan et al....[Show more]

CollectionsANU Research Publications
Date published: 2020
Type: Journal article
Source: Australian and New Zealand Journal of Psychiatry
DOI: 10.1177/0004867420910216


File Description SizeFormat Image
Reappraising prazosin.pdf135.21 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator